Current controversies in prenatal diagnosis 1: NIPT for chromosome abnormalities should be offered to women with low a priori risk

Prenatal Diagnosis

Volumn 35, Issue 1, 2015, Pages 8-14

  Van Lith, Jan M M ^a   Faas, Brigitte H W ^b   Bianchi, Diana W ^c  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME ABERRATION; DNA DETERMINATION; DOWN SYNDROME; HUMAN; NON INVASIVE PRENATAL TESTING; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; RELIABILITY; VALIDITY; BLOOD; CHROMOSOME DISORDERS; FEMALE; NEWBORN; PREGNANCY; PROCEDURES; RISK FACTOR;

CHROMOSOME DISORDERS; DOWN SYNDROME; FEMALE; HUMANS; INFANT, NEWBORN; PREGNANCY; PRENATAL DIAGNOSIS; RISK FACTORS;

EID: 84921508536     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.4530     Document Type: Article

References (29)

1. Lo YM, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997;350:485-7.
2. Special issue part I and II, noninvasive prenatal testing using maternal plasma DNA. Prenat Diagn 2013;33:511-710.
3. Benn P, Borrell A, Cuckle H, et al. Prenatal detection of Down syndrome using massively parallel sequencing (MPS): a rapid response statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, 24 October 2011. Prenat Diagn 2012;32:1-2.
4. Gregg AR, Gross SJ, Best RG, et al. ACMG statement on noninvasive prenatal screening for fetal aneuploidy. Genet Med 2013;15:395-8.
5. American College of Obstetricians and Gynecologists Committee on Genetics. Committee opinion No. 545: noninvasive prenatal testing for fetal aneuploidy. Obstet Gynecol 2012;120:1532-4.
6. Bianchi DW, Oepkes D, Ghidini A. Current controversies in prenatal diagnosis 1: should noninvasive DNA testing be the standard screening test for Down syndrome in all pregnant women? Prenat Diagn 2013;34:6-11.
7. Wilson JMG, Jungner G. Principles and Practice of Screening for Disease. WHO: Geneva, 1968.
8. Andermann A, Blancquaert I, Beauchamp S, Déry V. Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40years. Bull World Health Organ 2008;86:317-9.
9. Rump P, de Leeuw N, van Essen AJ, et al. Central 22q11.2 deletions. Am J Med Genet A 2014;164:2707-23.
10. Benn P, Chapman AR, Erickson K, et al. Obstetricians and gynecologists' practice and opinions of expanded carrier testing and noninvasive prenatal testing. Prenat Diagn 2014;34:145-52.
11. Wang Y, Chen Y, Tian F, et al. Maternal mosaicism is a significant contributor to discordant sex chromosomal aneuploidies associated with noninvasive prenatal testing. Clin Chem 2014;60:251-9.
12. Oepkes D, Yaron Y, Kozlowski P, et al. Counseling for non-invasive prenatal testing (NIPT): what pregnant women may want to know. Ultrasound Obstet Gynecol 2014;44:1-5.
13. Morris S, Karlsen S, Chung N, et al. Model-based analysis of costs and outcomes of noninvasive prenatal testing for Down's syndrome using cell-free DNA in the UK National Health Service. PLoS One 2014;9(4):e93559. doi:10.1371/journal.pone.0093559.
14. Bianchi DW, Wilkins-Haug L. Integration of noninvasive testing for aneuploidy into prenatal care: what has happened since the rubber met the road? Clin Chem 2014;60:78-87.
15. Holtzman NA, Watson MS. Promoting Safe and Effective Genetic Testing in the United States. Final Report of the Task Force on Genetic Testing. Johns Hopkins University Press: Baltimore, MD, 1999.
16. Burke W. Genetic tests: clinical validity and clinical utility. Curr Protoc Hum Genet 2014;9.15.1-9.15.8.
17. Futch T, Spinosa J, Bhatt S, et al. Initial clinical laboratory experience in noninvasive prenatal testing for fetal aneuploidy from maternal plasma DNA samples. Prenat Diagn 2013;33:569-74.
18. Pergament E, Cuckle H, Zimmermann B, et al. Single-nucleotide polymorphism-based noninvasive prenatal screening in a high-risk and low-risk cohort. Obstet Gynecol 2014;124:210-8.
19. Song Y, Liu C, Zhang Y, et al. Noninvasive prenatal testing of fetal aneuploidies by massively parallel sequencing in a prospective Chinese population. Prenat Diagn 2013;33:700-6.
20. Bianchi DW, Parker RL, Wentworth J, et al. DNA sequencing versus standard prenatal aneuploidy screening. N Engl J Med 2014;370:799-808.
21. st trimester combined screening for trisomy 21 risk assessment in a large routine pregnancy population. Eur J Hum Genet 2014; 22(Suppl1):abstract P01.014, page 53.
22. Gil MM, Quezada MS, Bregant B, et al. Implementation of maternal blood cell-free DNA testing in early screening for aneuploidies. Ultrasound Obstet Gynecol 2013;42:34-40.
23. Nicolaides KH, Wright D, Poon LC, et al. First-trimester contingent screening for trisomy 21 by biomarkers and maternal blood cell-free DNA testing. Ultrasound Obstet Gynecol 2013;42:41-50.
24. Liao C, Yin A, Peng C, et al. Noninvasive prenatal diagnosis of common aneuploidies by semiconductor sequencing. Proc Natl Acad Sci U S A 2014;111:7415-20.
25. Wang Y, Wen Z, Shen J, et al. Comparison of the performance of Ion Torrent chips in noninvasive prenatal trisomy detection. J Hum Genet 2014; doi:10. 1038/jhg.2014.40.
26. Yu SC, Chan KC, Zheng YW, et al. Size-based molecular diagnostics using plasma DNA for noninvasive prenatal testing. Proc Natl Acad Sci U S A 2014; 111:8583-8.
27. Larion S, Warsof SL, Romary L, et al. Association of combined first-trimester screen and noninvasive prenatal testing on diagnostic procedures. Obstet Gynecol 2014;123:1303-10.
28. Osborne CM, Hardisty E, Devers P, et al. Discordant noninvasive prenatal testing results in a patient subsequently diagnosed with metastatic disease. Prenat Diagn 2013;33:609-11.
29. Rose NC, Lagrave D, Hafen B, Jackson M. The impact of utilization of early aneuploidy screening on amniocenteses available for training in obstetrics and fetal medicine. Prenat Diagn 2013;33:242-4.